|
Sign In to gain access to subscriptions and/or personal tools.
|
Clinical and Applied Thrombosis/Hemostasis, Vol. 12, No. 4,
445-450 (2006)
DOI: 10.1177/1076029606293420
The Use of a Surgical Patch Coated With Human Coagulation Factors in Surgical Routine: A Multicenter Postauthorization Surveillance
Sylvia Haas, MD
Institut für Experimentelle Onkologie und Therapieforschung, Technische Universität München, Germany, sylvia.haas{at}lrz.tum.de
Local hemostyptic agents are of great value to significantly reduce bleeding complications and various devices have become available for clinical use. The aim of this multicenter postauthorization surveillance was to study the surgeons’ expectations regarding efficacy and safety of the surgical patch coated with human coagulation factors (TachoSil) under routine clinical conditions. A total of 408 patients had been included in this trial and the patients had to have an expected increased bleeding risk either due to patient related hemorrhagic risk factors or operations associated with an expected increase of bleeding complications. The main types of surgical interventions were operations on the liver (26%), vascular system (16%), gastrointestinal tract (10%), heart (8%), kidney (7%), thorax (7%), spleen (4%), and pancreas (4%). Other operations (18%) were reported in the fields of neurosurgery, urology, gynecology, dermatology, and on the thyroid gland. Based on subjective assessments the results have shown that TachoSil has met the surgeons’ expectations to be efficacious and safe as a hemostatic treatment in a broad variety of surgical interventions. The observed benefits far exceed the frequencies of complications and many of the observed benefits easily translate into cost savings. In almost 50% of the cases the surgeons thought that the use of the topical hemostat TachoSil may have led to savings in blood component therapy. The savings of intra- and postoperative transfusions may lead to less frequent transfusion-related adverse effects and the lower probability of postoperative complications is of clinical importance. In particular, it is worth mentioning that based on the surgeons’ assessment, the use of TachoSil may have helped to save the organ in 17% of the cases. Thus, these clinically relevant benefits may offer opportunities for improvements of hemostasis in patients at risk for bleeding complications and may facilitate the management of excessive bleeding.
Key Words: Surgical patch • Local hemostasis • Postoperative bleeding
References
- Aziz O, Athanasiou T, Darzi A. Haemostasis using a ready-to-use collagen sponge coated with activated thrombin and fibrinogen. Surg Technol Int. 2005; 14: 35-40.[Medline]
[Order article via Infotrieve]
- Frilling A, Stavrou GA, Mischinger HJ, et al. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg. 2005; 390: 114-120.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Czerny M, Fleck T, Salat A, et al. Sealing of the mediastinum with a local hemostyptic agent reduces chest tube duration after complete mediastinal lymph node dissection for stage I and II non-small cell lung carcinoma. Ann Thorac Surg. 2004; 77: 1028-1032.[Abstract/Free Full Text]
- Lang G, Csekeö A, Stamatis G, et al. Efficacy and safety of topical application of human fibrinogen/thrombin-coated collagen patch (TachoComb) for treatment of air leakage after standard lobectomy. Eur J Cardiothorac Surg. 2004; 25: 160-166[Abstract/Free Full Text]
- Schuetz A, Schulze C, Wildhirt SM. Off-pump epicardial tissue sealing—a novel method for atrioventricular disruption complicating mitral valve procedures. Ann Thorac Surg. 2004; 78: 569-573.[Abstract/Free Full Text]
- Joseph T, Adeosun A, Paes T, Bahal V. Randomised controlled trial to evaluate the efficacy of TachoComb H patches in controlling PTFE suture-hole bleeding. Eur J Vasc Endovasc Surg. 2004; 27(5): 549-552.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Carbon RT, Baar S, Waldschmidt J, Huemmer HP, Simon SI. Innovative minimally invasive pediatric surgery is of therapeutic value for splenic injury. J Pediatr Surg. 2002; 37: 1146-1150.[CrossRef][ISI][Medline]
[Order article via Infotrieve]
- Schwaitzberg SD, Chan MW, Cole DJ, et al. Comparison of poly-N-acetyl glucosamine with commercially available topical hemostats for achieving hemostasis in coagulopathic models of splenic hemorrhage. J Trauma. 2004; 57(1 Suppl): S29-S32.[ISI][Medline]
[Order article via Infotrieve]
- Reddy M, Schöggl A, Reddy B, Saringer W, Weigel G, Matula C. A clinical study of a fibrinogen-based collagen fleece for dural repair in neurosurgery. Acta Neurochir (Wien). 2002; 144: 265-269[CrossRef][Medline]
[Order article via Infotrieve]
- Lawson JH, Lynn KA, Vanmatre RM, et al. Antihuman factor V antibodies after use of relatively pure bovine thrombin. Ann Thorac Surg. 2005; 79(3): 1037-1038.[Abstract/Free Full Text]
- Adelmann-Grill BC, Otto K. Immunological safety evaluation of a haemostatic agent and wound dressing made of horse collagen fibrils. Drug Res. 1987; 37: 802-805.[Medline]
[Order article via Infotrieve]
- Joch C. The safety of fibrin sealants. Cardiovasc Surg. 2003; 11(Suppl 1): 23-28.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
|
